1
/
of
1
NSJ Bioreagents
SKU:V9717-100UG
Recombinant KRT20 Antibody / Cytokeratin 20, 100 ug
Recombinant KRT20 Antibody / Cytokeratin 20, 100 ug
Regular price
$559.00 USD
Regular price
Sale price
$559.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
This MAb recognizes an intermediate filament protein of 46kDa, identified as CK20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
Specifications
| Catalog No | V9717-100UG |
|---|---|
| Family | Primary antibody |
| Qty | 100 ug |
| Formulation | 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide |
| Format | Purified |
| Clone | KRT20/4380R |
| Host Animal | Rabbit |
| Clonality | Recombinant Rabbit Monoclonal |
| Isotype | Rabbit IgG, kappa |
| Species Reactivity | Human |
| Application | IHC-P |
| Application Details | Immunohistochemistry (FFPE): 1-2ug/ml |
| Application Note | Optimal dilution of the recombinant KRT20 antibody should be determined by the researcher. |
| Localization | Cytoplasm |
| Immunogen | A portion of amino acids 324 424 was used as the immunogen for the recombinant KRT20 antibody. |
| Purity | Protein A/G affinity |
| Storage | Aliquot the recombinant KRT20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles. |
| Limitation | This recombinant KRT20 antibody is available for research use only. |
| Uniprot # | P35900 |
| Status | Available |
| PDF Link | https://www.nsjbio.com/tds-pdf/recombinant-krt20-antibody-cytokeratin-20-krt204380r-v9717 |
| Title | Recombinant KRT20 Antibody / Cytokeratin 20 |
| Description | This MAb recognizes an intermediate filament protein of 46kDa, identified as CK20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive. |
Share
